Earnings Feed
Start Free
EyePoint Pharmaceuticals, Inc.·4

Jan 9, 8:55 PM ET

Landis John B. 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 9, 2024

Insider Transaction Report

Form 4
Period: 2024-01-05
EyePoint Pharmaceuticals, Inc.EYPT
Landis John B.
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-05+25,014→ 25,014 total
    Exercise: $20.40From: 2025-01-05Exp: 2034-01-04→ Common Stock (25,014 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-01-05+20,000→ 20,000 total
    Exercise: $20.40From: 2025-01-05Exp: 2034-01-04→ Common Stock (20,000 underlying)
  • Award

    Restricted Stock Units

    2024-01-05+10,000→ 10,000 total
    Exercise: $0.00From: 2025-01-05Exp: 2034-01-04→ Common Stock (10,000 underlying)

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT